What Chugai Pharma Germany does

Chugai Pharma Germany GmbH is the German operating subsidiary of Chugai Pharmaceutical Co., Ltd. (Japan), a specialty pharmaceutical company majority-owned by Roche since the 2002 strategic alliance. Headquartered in Frankfurt am Main, the German entity markets prescription pharmaceutical products (including Tocilizumab) in three therapeutic areas — rheumatology, hemophilia, and oncology — through the standard German pharmaceutical distribution chain. Revenue derives from product sales of prescription medicines, with no public disclosure of subsidiary-level financials; the entity's results consolidate into Chugai Pharmaceutical and ultimately into Roche's group accounts.

The company's principal go-to-market asset is its Medical Education portal (chugai-medicaleducation.de), a German-language content platform built on a modular CMS with DocCheck-gated access for verified healthcare professionals. The platform serves rheumatologists, hematologists, oncologists, and Rheumatologische Fachassistenz (RFA) staff with congress summaries (ACR, EULAR, DGRh, ISTH, GTH, EAHAD, ASH), CME-accredited programs (RheumaConnect RZA im Fokus, 7 CME points), podcast series (INtoRHEUMA, WohlDosiert), and condition-specific medical materials. The technology stack includes Matomo analytics, DocCheck identity verification, the IQVIA OneKey HCP database for targeting, and integration with patient-facing resources (Active-A for hemophilia A, Deutsche Rheuma-Liga).

The entity operates three managing directors and a Medical Education team of named scientific staff, and is a member of the German pharma self-regulation bodies AKG and FSA, publishing annual transparency reports on transfers of value to HCPs and patient organizations. Distribution combines direct medical affairs engagement, in-person Qualitätszirkel training events for RFAs, and digital self-service access to educational content, with product distribution handled through authorized German pharmaceutical wholesalers to pharmacies and hospitals.

Name

Chugai Pharma Germany

Legal name

Chugai Pharma Germany GmbH

Website

https://chugai-medicaleducation.de

Company type

Private

Founded year

1925

Operating status

Operating

Short description

Chugai Pharma Germany GmbH is the German subsidiary of Chugai Pharmaceutical (Roche Group), marketing specialty prescription drugs in rheumatology, hemophilia, and oncology through a DocCheck-gated Medical Education portal serving German healthcare professionals and Rheumatologische Fachassistenz.

Ownership category

akta.pro rank

Product category

Specialty Pharmaceuticals

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industries

Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD), Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)

Keywords

• Prescription pharmaceuticals
• Medical education services
• Rheumatology treatments
• Hemophilia therapies
• Oncology medicines

Headquarters

HQ city

Frankfort

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Marketing or Sales, Technology or R&D, Operations, Supply Chain

Revenue model

1. Pharmaceutical product sales (prescription medicines): Chugai Pharma Germany operates as the German subsidiary of Chugai Pharmaceutical (Japan). The company markets prescription pharmaceutical products in rheumatology (e.g., Tocilizumab), hemophilia, and oncology. As a subsidiary of Chugai Pharmaceutical (majority-owned by Roche), revenue derives from product sales through the standard pharmaceutical distribution chain in Germany.
2. Medical education and scientific engagement: Chugai Pharma Germany's Medical Education portal provides scientific and medical information to healthcare professionals as part of the company's medical affairs and scientific engagement activities, supporting product knowledge and clinical practice in aligned therapeutic areas.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels10 records

Core offering

Chugai Pharma Germany GmbH markets and distributes prescription pharmaceutical products in rheumatology, hemophilia, and oncology as the German subsidiary of Chugai Pharmaceutical Co., Ltd. (Japan). The company operates the Medical Education portal (chugai-medicaleducation.de), delivering scientifically curated content, congress summaries, CME-accredited programs, podcasts, and shared decision-making tools to German healthcare professionals and patients. Pharmaceutical products such as Tocilizumab are sold through the standard German pharmaceutical distribution chain.

Product overview

Chugai Pharma Germany's Medical Education platform is a multi-module educational system serving healthcare professionals and patients in three therapeutic areas: Rheumatology, Hemophilia, and Oncology. The core platform provides congress summaries, medical materials, and product information, supplemented by specialized educational programs like RheumaConnect (RZA im Fokus, Journal Club), RFA Qualitätszirkel training, and the Chugai Cancer Summit. Patient-facing resources include the Therapieentscheidungshilfe Hämophilie decision support tool, HaemMotion, and the RA Wegweiser guide. The DiGA service provides information on digital health applications. Key products are distributed through authenticated DocCheck login for healthcare professionals, with some materials available publicly.

Differentiator

Problem solved

Functional benefit

Products and services

• Prescription Pharmaceutical Products (Rheumatology, Hemophilia, Oncology)

Quantifiable outcome

• CME-accredited programs: RheumaConnect RZA im Fokus offers 7 CME points; Expertise und Innovation webinar offers 2 CME points.
• +2 more outcomes

Named customers6 records

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature6 records

Partnerships

Eight partnerships are on record, tiered core, supporting and minor.

• Arzneimittel und Kooperation im Gesundheitswesen e.V. (AKG)coreOthers · 1 January 2016AKG is a German pharmaceutical industry association. Chugai Pharma Germany is a member and participates in the AKG transparency code, publishing annual reports on all financial transfers to medical professionals and patient organizations since 2016.
• Freiwillige Selbstkontrolle für die Arzneimittelindustrie e.V. (FSA)coreOthers · 1 January 2016FSA is the German voluntary self-regulation body for the pharmaceutical industry. Chugai Pharma Germany is a member and participates in the FSA transparency code, publishing annual reports on financial transfers to medical professionals and patient organizations since 2016.
• Active-A (Leben mit Hämophilie A)coreGTM or Marketing PartnerActive-A is a patient-facing website for people living with hemophilia A, managed or supported by Chugai Pharma Germany. It provides current reports, blog posts, and information from patients with hemophilia A, serving as a patient engagement and support channel linked from the Chugai Medical Education portal.
• Deutsche Rheuma-LigacoreGTM or Marketing PartnerDeutsche Rheuma-Liga is Germany's largest national self-help organization for people with rheumatic diseases, referenced on Chugai's patient information pages as a recommended resource for patients. The partnership supports patient referrals and disease awareness in rheumatology.
• Fachverband Rheumatologische Fachassistenz e.V.coreStrategic or Co-development PartnerThe professional association for rheumatological specialist assistants (RFAs) in Germany. Chugai partners with this association through the RheumaConnect and Qualitätszirkel programs, with Patricia Steffens-Korbanka serving as 2nd Chair of the association and co-hosting Chugai's WohlDosiert podcast series.
• IQVIA Commercial GmbH & Co. OHGsupportingTechnology or IntegrationChugai Pharma Germany uses IQVIA's OneKey database containing current master, contact, and specialization data for medical professionals in Germany. Data is used for customer relationship management and HCP targeting, based on legitimate interest under Art. 6(1)(f) GDPR.
• DocCheck Medical Services GmbHcoreTechnology or IntegrationDocCheck provides medical professional verification (Login) for the Chugai Medical Education portal, ensuring that prescription drug information is accessible only to verified members of medical professions, in compliance with German pharmaceutical advertising regulations.
• KITASATO (Online Symposia Platform)minorOthersChugai Medical Education references KITASATO as a platform for hosting online symposia, as mentioned in the News section of the portal where new online symposia are announced.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Chugai Pharma Germany